Authors' Reply

Affiliations

¹ Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
² Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

Free article

Comment

Suman Patra et al. Indian J Dermatol Venereol Leprol. 2022 Mar-Apr.

Free article

. 2022 Mar-Apr;88(2):213.

doi: 10.25259/IJDVL_870_2021.

¹ Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
² Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.

No abstract available

Comment on

A combination of trimethoprim/sulfamethoxazole with linezolid is useful for actinomycotic mycetoma: A summary of the existing data and the rationale of combination therapy.
Sardana K, Sachdeva S. Sardana K, et al. Indian J Dermatol Venereol Leprol. 2022 Mar-Apr;88(2):212-213. doi: 10.25259/IJDVL_539_2021. Indian J Dermatol Venereol Leprol. 2022. PMID: 34877844 No abstract available.

1. Sardana K, Sachdeva S,. A combination of trimethoprim/sulfamethoxazole with linezolid is useful for actinomycotic mycetoma: A summary of the existing data and the rationale of combination therapy. Indian J Dermatol Venereol Leprol. 2022; 88:212-3
1. Patra S, Senthilnathan G, Ramam M, Arava S, Bhari N,. Linezolid: A novel treatment option for the treatment of a non-responsive case of actinomycotic mycetoma. Indian J Dermatol Venereol Leprol. 2021; 87:455